The regulatory agency’s responsibility is to provide advice to sponsors by answering questions related to development of medicinal products that sponsors have specified in an appropriate application form and sent to the regulatory agency. The advice given (either in writing, via video/telephone conference or at a meeting) is not binding, neither on the regulatory agency nor on the sponsor.
